Endocrine Society Letter to CMS Regarding a 90-Day Supply of Diabetes Test Strips During COVID-19

To: CMS Administrator Seema Verma

"Blood glucose self-testing equipment and supplies, like test strips, are covered as durable medical equipment (DME) for all people with Medicare Part B who have diabetes. Medicare will cover up to 100 test strips for 30 days for insulin-dependent beneficiaries. Patients with diabetes check their blood glucose at least once per day and those who are insulin-dependent are recommended to check their levels three times per day. Blood glucose control is even more significant when a patient is ill, as glucose levels are the first impacted by an illness. For these reasons, it is critical that beneficiaries have coverage for a 90-day supply of test strips during the current public health emergency so they can maintain good glucose control and reduce the risk of infection."

Read the Full Letter